Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

331 ARTÍCULOS , VIENDO DEL 316 AL 330

Ferulic acid and Alzheimer's disease: promises and pitfalls

Nabavi SF, Devi KP, Malar DS, Sureda A, Daglia M, Nabavi SM.

Mini Rev Med Chem. 2015;15(9):776-88. doi: 10.2174/1389557515666150522102545.

Mitochondria-Targeted Protective Compounds in Parkinson's and Alzheimer's Diseases

Fernández-Moriano C, González-Burgos E, Gómez-Serranillos MP.

Oxid Med Cell Longev. 2015;2015:408927. doi: 10.1155/2015/408927. Epub 2015 Apr 29.

Impact of the Alzheimer's Disease Neuroimaging Initiative, 2004 to 2014

Weiner MW, Veitch DP, Aisen PS, Beckett LA, Cairns NJ, Cedarbaum J, Donohue MC, Green RC, Harvey D, Jack CR Jr, Jagust W, Morris JC, Petersen RC, Saykin AJ, Shaw L, Thompson PM, Toga AW, Trojanowski JQ; Alzheimer's Disease Neuroimaging Initiative.

Alzheimers Dement. 2015 Jul;11(7):865-84. doi: 10.1016/j.jalz.2015.04.005.

Trial design innovations: Clinical trials for treatment of neuropsychiatric symptoms in Alzheimer's Disease

Cummings J, Zhong K.

Clin Pharmacol Ther. 2015 Nov;98(5):483-5. doi: 10.1002/cpt.190. Epub 2015 Aug 31.

The Third French Alzheimer Plan: analysis of the influence of a national public health initiative on scientific research productivity and impact

Haeffner-Cavaillon N, Devos P, Ledoux S, Ménard J.

Alzheimers Res Ther. 2015 Sep 26;7(1):60. doi: 10.1186/s13195-015-0144-z.

Changes in Nutritional Status after Deep Brain Stimulation of the Nucleus Basalis of Meynert in Alzheimer's Disease--Results of a Phase I Study

Noreik M, Kuhn J, Hardenacke K, Lenartz D, Bauer A, Bührle CP, Häussermann P, Hellmich M, Klosterkötter J, Wiltfang J, Maarouf M, Freund HJ, Visser-Vandewalle V, Sturm V, Schulz RJ.

J Nutr Health Aging. 2015 Oct;19(8):812-8. doi: 10.1007/s12603-015-0595-8.

Neuroethical implications of deep brain stimulation in degenerative disorders

Ovadia D, Bottini G.

Curr Opin Neurol. 2015 Dec;28(6):598-603. doi: 10.1097/WCO.0000000000000263.

Applications of Nanotechnology in Diagnostics and Therapeutics of Alzheimer's and Parkinson's Disease

Soursou G, Alexiou A, Ashraf GM, Siyal AA, Mushtaq G, Kamal MA.

Curr Drug Metab. 2015;16(8):705-12. doi: 10.2174/138920021608151107125049.

Deep Assessment: A Novel Framework for Improving the Care of People with Very Advanced Alzheimer's Disease

Lyons G, Arthur-Kelly M, Eidels A, Mavratzakis A.

Biomed Res Int. 2015;2015:749451. doi: 10.1155/2015/749451. Epub 2015 Nov 24.

Flavonoid-based therapies in the early management of neurodegenerative diseases

Solanki I, Parihar P, Mansuri ML, Parihar MS.

Adv Nutr. 2015 Jan 15;6(1):64-72. doi: 10.3945/an.114.007500. Print 2015 Jan.

Nonpeptide neurotrophic agents useful in the treatment of neurodegenerative diseases such as Alzheimer's disease

Akagi M, Matsui N, Akae H, Hirashima N, Fukuishi N, Fukuyama Y, Akagi R.

J Pharmacol Sci. 2015 Feb;127(2):155-63. doi: 10.1016/j.jphs.2014.12.015. Epub 2015 Jan 13.

Anti-dementia drugs-related changes in gait performance while single and dual tasking in patients with Alzheimer disease: a meta-analysis

Beauchet O, Launay CP, Montero-Odasso M, Annweiler C, Allali G.

Curr Alzheimer Res. 2015;12(8):761-71. doi: 10.2174/1567205012666150710111341.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias